Zdrowie i gospodarka · 01/08/2019

FDA Announces Final Guidance for Industry on Developing Drugs for Vulvovaginal Candidiasis Treatment

The US Food and Drug Administration (FDA) has released a final guidance document to help pharmaceutical companies develop effective treatments for vulvovaginal candidiasis (VVC), a common fungal infection, and to support clinical trials for new drugs targeting this condition.